MLMaureen C. Lamb

Maureen C. Lamb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maureen C. Lamb has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    NR6A1 is essential for neural crest cell specification, formation and survival

    by Emma L. Moore Zajic, William A. Muñoz, Jennifer F Dennis, Shachi Bhatt, Daisuke Sakai, Annita Achilleos, Ruonan Zhao, Maureen Lamb, Andrew J Price, Chris Seidel, et al.

    Neural crest cells (NCC) are a migratory progenitor cell population considered unique to vertebrates. Derived from the neuroepithelium during early embryogenesis, NCC contribute to nearly every tissue and organ system throughout the body, and disruptions in NCC development can result in congenital disorders, termed neurocristopathies. Despite decades of research, we have a poor understanding of the cellular mechanisms and signals that govern mammalian NCC formation. We discovered nuclear receptor superfamily 6 group member 1 (NR6A1/GCNF/RTR), is a novel, critical regulator of mammalian NCC specification, formation and survival. Nr6a1 is expressed throughout the neuroepithelium in mouse embryos from E8.0 to E9.5 and briefly in newly delaminated NCC. Nr6a1 loss-of-function perturbs anterior cranial NCC formation and survival, and results in the complete agenesis of migratory NCC caudal to the first pharyngeal arch. Using mouse ESC and human iPSC differentiation into NCC, chromatin immunoprecipitation, and multiomic approaches, we demonstrate that these phenotypes are associated with perturbation of NCC specification ( Foxd3, Sox9, Sox10 ) and epithelial-mesenchymal transition (EMT; Snail1, Zeb2 ), in concert with persistent expression of pluripotency-associated factors ( Oct4 and Nanog ) in the neuroepithelium. Conditional deletion revealed that Nr6a1 is required during mid-late gastrulation, demonstrating that murine NCC specification occurs earlier than previously thought. Consistent with these observations, in vivo overexpression of Oct4 in gastrulating mouse embryos disrupts NCC specification and formation. Therefore, Nr6a1 is essential for mammalian NCC formation and moreover, may function as a bimodal switch repressing pluripotency-associated factors in the neuroepithelium, while concomitantly activating NCC specifiers and regulators of EMT.


  • Open Access

    rRNA transcription is integral to phase separation and maintenance of nucleolar structure

    by Soma Dash, Maureen C. Lamb, Jeffrey J. Lange, Mary C. McKinney, Dai Tsuchiya, Fengli Guo, Xia Zhao, Timothy J. Corbin, MaryEllen Kirkman, Kym Delventhal, et al.

    Transcription of ribosomal RNA (rRNA) by RNA Polymerase (Pol) I in the nucleolus is necessary for ribosome biogenesis, which is intimately tied to cell growth and proliferation. Perturbation of ribosome biogenesis results in tissue specific disorders termed ribosomopathies in association with alterations in nucleolar structure. However, how rRNA transcription and ribosome biogenesis regulate nucleolar structure during normal development and in the pathogenesis of disease remains poorly understood. Here we show that homozygous null mutations in Pol I subunits required for rRNA transcription and ribosome biogenesis lead to preimplantation lethality. Moreover, we discovered that Polr1a-/-, Polr1b-/-, Polr1c-/- and Polr1d-/- mutants exhibit defects in the structure of their nucleoli, as evidenced by a decrease in number of nucleolar precursor bodies and a concomitant increase in nucleolar volume, which results in a single condensed nucleolus. Pharmacological inhibition of Pol I in preimplantation and midgestation embryos, as well as in hiPSCs, similarly results in a single condensed nucleolus or fragmented nucleoli. We find that when Pol I function and rRNA transcription is inhibited, the viscosity of the granular compartment of the nucleolus increases, which disrupts its phase separation properties, leading to a single condensed nucleolus. However, if a cell progresses through mitosis, the absence of rRNA transcription prevents reassembly of the nucleolus and manifests as fragmented nucleoli. Taken together, our data suggests that Pol I function and rRNA transcription are required for maintaining nucleolar structure and integrity during development and in the pathogenesis of disease.


  • Open Access

    rRNA transcription is integral to liquid-liquid phase separation and maintenance of nucleolar structure

    by Soma Dash, Maureen C. Lamb, Jeffrey J. Lange, Mary C. McKinney, Dai Tsuchiya, Fengli Guo, Xia Zhao, Timothy J. Corbin, MaryEllen Kirkman, Kym Delventhal, et al.

    Summary: Beginning with transcription of ribosomal RNA (rRNA) by RNA Polymerase (Pol) I in the nucleolus, ribosome biogenesis is intimately tied to cell growth and proliferation. Perturbation of ribosome biogenesis has been previously shown to affect nucleolar structure, yet the underlying mechanism is unknown. We generated loss-of-function mouse mutants of Pol I subunits, Polr1a, Polr1b, Polr1c and Polr1d , thereby genetically inhibiting rRNA transcription and ribosome biogenesis. Pol I mutant embryos are preimplantation lethal and have fewer nucleoli. Using hiPSCs triple labeled for the three nucleolar compartments, we observe two phenotypes upon Pol I inhibition: a single condensed nucleolus, and fragmented nucleoli. We find that when rRNA transcription is inhibited, the viscosity of the granular compartment of the nucleolus is increased disrupting its liquid-liquid phase separation properties, which results in a condensed nucleolus. Taken together, our data suggests that Pol I function and rRNA transcription are required for maintaining nucleolar structure and integrity.


  • Open Access

    Fascin limits Myosin activity within Drosophila border cells to control substrate stiffness and promote migration

    by Maureen C Lamb, Chathuri P Kaluarachchi, Thiranjeewa I Lansakara, Samuel Q Mellentine, Yiling Lan, Alexei V Tivanski, Tina L Tootle

    A key regulator of collective cell migrations, which drive development and cancer metastasis, is substrate stiffness. Increased substrate stiffness promotes migration and is controlled by Myosin. Using Drosophila border cell migration as a model of collective cell migration, we identify, for the first time, that the actin bundling protein Fascin limits Myosin activity in vivo. Loss of Fascin results in: increased activated Myosin on the border cells and their substrate, the nurse cells; decreased border cell Myosin dynamics; and increased nurse cell stiffness as measured by atomic force microscopy. Reducing Myosin restores on-time border cell migration in fascin mutant follicles. Further, Fascin’s actin bundling activity is required to limit Myosin activation. Surprisingly, we find that Fascin regulates Myosin activity in the border cells to control nurse cell stiffness to promote migration. Thus, these data shift the paradigm from a substrate stiffness-centric model of regulating migration, to uncover that collectively migrating cells play a critical role in controlling the mechanical properties of their substrate in order to promote their own migration. This understudied means of mechanical regulation of migration is likely conserved across contexts and organisms, as Fascin and Myosin are common regulators of cell migration.


  • Open Access

    Fascin limits Myosin activity within Drosophila border cells to control substrate stiffness and promote migration

    by Maureen C. Lamb, Chathuri P. Kaluarachchi, Thiranjeewa I. Lansakara, Yiling Lan, Alexei V. Tivanski, Tina L. Tootle

    A key regulator of collective cell migrations, which drive development and cancer metastasis, is substrate stiffness. Increased substrate stiffness promotes migration and is controlled by Myosin. Using Drosophila border cell migration as a model of collective cell migration, we identify, for the first time, that the actin bundling protein Fascin limits Myosin activity in vivo . Loss of Fascin results in: increased activated Myosin on the border cells and their substrate, the nurse cells; decreased border cell Myosin dynamics; and increased nurse cell stiffness as measured by atomic force microscopy. Reducing Myosin restores on-time border cell migration in fascin mutant follicles. Further, Fascin’s actin bundling activity is required to limit Myosin activation. Surprisingly, we find that Fascin regulates Myosin activity in the border cells to control nurse cell stiffness to promote migration. Thus, these data shift the paradigm from a substrate stiffness-centric model of regulating migration, to uncover that collectively migrating cells play a critical role in controlling the mechanical properties of their substrate in order to promote their own migration. This new means of mechanical regulation of migration is likely conserved across contexts and organisms, as Fascin and Myosin are common regulators of cell migration.


  • Defining the functions of the actin bundling protein fascin in invasive, collective cell migration

    by Maureen C. Lamb, Tina L Tootle, Sheila Baker, Martine Dunnwald, Dawn Quelle, Bryan Phillips

    Cell migration, or the movement of a cell, is an essential process in the body. However, most research has focused on how individual cells migrate rather than how groups, or collectives, of cells migrate. Understanding collective cell migration is critical because many cells in our bodies migrate as collectives. During embryonic development, many cells collectively migrate to form the tissues and organs. However, in diseases such as cancer, collective cell migration can be hijacked to lead to cancer metastasis, the process by which cancer spreads throughout the body. One of the proteins known to play a role in cell migration is Fascin. Fascin promotes migration and metastasis in many types of cancer, leading to more aggressive disease. Yet how Fascin promotes collective cell migration is not well understood. Here, I use a model of collective cell migration in the ovary of the fruit fly, Drosophila melanogaster, called border cell migration. I found that Fascin acts both in the migrating cells and their surroundings to promote border cell migration. I also discovered that Fascin promotes border cell migration in many different ways, including regulating the stiffness of the migrating cells and their surroundings. These new functions of Fascin may lead to a better understanding of how Fascin promotes collective cell migrations in humans, such as in cancer metastasis. Ultimately, the work presented in this thesis demonstrates how the border cell migration, in the fruit fly, can be used as a model to better understand the mechanisms driving human diseases such as cancer metastasis.

  • Open Access

    Fascin in Cell Migration: More Than an Actin Bundling Protein

    by Maureen C. Lamb, Tina L. Tootle

    Fascin, an actin-binding protein, regulates many developmental migrations and contributes to cancer metastasis. Specifically, Fascin promotes cell motility, invasion, and adhesion by forming filopodia and invadopodia through its canonical actin bundling function. In addition to bundling actin, Fascin has non-canonical roles in the cell that are thought to promote cell migration. These non-canonical functions include regulating the activity of other actin-binding proteins, binding to and regulating microtubules, mediating mechanotransduction to the nucleus via interaction with the Linker of the Nucleoskeleton and Cytoskeleton (LINC) Complex, and localizing to the nucleus to regulate nuclear actin, the nucleolus, and chromatin modifications. The many functions of Fascin must be coordinately regulated to control cell migration. While much remains to be learned about such mechanisms, Fascin is regulated by post-translational modifications, prostaglandin signaling, protein–protein interactions, and transcriptional means. Here, we review the structure of Fascin, the various functions of Fascin and how they contribute to cell migration, the mechanisms regulating Fascin, and how Fascin contributes to diseases, specifically cancer metastasis.


  • Prostaglandins regulate invasive, collective border cell migration

    by Emily F. Fox, Maureen C. Lamb, Samuel Q. Mellentine, Tina L. Tootle

    Prostaglandins regulate the actin bundler Fascin to promote both on-time border cell migration and cluster cohesion. The latter involves regulating integrin-based adhesions.


  • Fascin regulates protrusions and delamination to mediate invasive, collective cell migration in vivo

    by Maureen C. Lamb, Kelsey K. Anliker, Tina L. Tootle

    Background: The actin bundling protein Fascin is essential for developmental cell migrations and promotes cancer metastasis. In addition to bundling actin, Fascin has several actin‐independent roles; how these other functions contribute to cell migration remains unclear. Border cell migration during Drosophila oogenesis provides an excellent model to study Fascin's various roles during invasive, collective cell migration.Results: On‐time border cell migration during Stage 9 requires Fascin (Drosophila Singed). Fascin functions not only within the migrating border cells, but also within the nurse cells, the substrate for this migration. Fascin genetically interacts with the actin elongation factor Enabled to promote on‐time Stage 9 migration and overexpression of Enabled suppresses the defects seen with loss of Fascin. Loss of Fascin results in increased, shorter and mislocalized protrusions during migration. Additionally, loss of Fascin inhibits border cell delamination and increases E‐Cadherin (Drosophila Shotgun) adhesions on both the border cells and nurse cells.Conclusions: Overall, Fascin promotes on‐time border cell migration during Stage 9 and contributes to multiple aspects of this invasive, collective cell migration, including both protrusion dynamics and delamination. These findings have implications beyond Drosophila, as border cell migration has emerged as a model to study mechanisms mediating cancer metastasis.


  • Open Access

    Pharmaco-Genetic Screen To Uncover Actin Regulators Targeted by Prostaglandins DuringDrosophilaOogenesis

    by Andrew J. Spracklen, Maureen C. Lamb, Christopher M. Groen, Tina L. Tootle

    Prostaglandins (PGs) are lipid signaling molecules with numerous physiologic functions, including pain/inflammation, fertility, and cancer. PGs are produced downstream of cyclooxygenase (COX) enzymes, the targets of non-steroidal anti-inflammatory drugs (NSAIDs). In numerous systems, PGs regulate actin cytoskeletal remodeling, however, their mechanisms of action remain largely unknown. To address this deficiency, we undertook a pharmaco-genetic interaction screen during late-stage Drosophila oogenesis. Drosophila oogenesis is as an established model for studying both actin dynamics and PGs. Indeed, during Stage 10B, cage-like arrays of actin bundles surround each nurse cell nucleus, and during Stage 11, the cortical actin contracts, squeezing the cytoplasmic contents into the oocyte. Both of these cytoskeletal properties are required for follicle development and fertility, and are regulated by PGs. Here we describe a pharmaco-genetic interaction screen that takes advantage of the fact that Stage 10B follicles will mature in culture and COX inhibitors, such as aspirin, block this in vitro follicle maturation. In the screen, aspirin was used at a concentration that blocks 50% of the wild-type follicles from maturing in culture. By combining this aspirin treatment with heterozygosity for mutations in actin regulators, we quantitatively identified enhancers and suppressors of COX inhibition. Here we present the screen results and initial follow-up studies on three strong enhancers - Enabled, Capping protein, and non-muscle Myosin II Regulatory Light Chain. Overall, these studies provide new insight into how PGs regulate both actin bundle formation and cellular contraction, properties that are not only essential for development, but are misregulated in disease.